Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : The Critical Investing Workshop -- Ignore unavailable to you. Want to Upgrade?

To: Voltaire who wrote (6233)	3/6/2000 2:05:00 PM
From: Jenne	Respond to of 35685

LightPath Technologies Announces Product Qualification by Avanex Corporation PR NEWSWIRE - March 06, 2000 08:31 ALBUQUERQUE, N.M., Mar 6, 2000 /PRNewswire via COMTEX/ -- LightPath Technologies, Inc. (Nasdaq: LPTHA) announced today that it has been qualified by Avanex Corporation (Nasdaq: AVNX) to supply high-performance optical components for its telecommunications products. The custom optics were designed specifically for Avanex and incorporate LightPath's proprietary GRADIUM(R) glass technology. Currently, Avanex is qualifying several other LightPath telecommunications products, including customized versions of the company's standard collimator products. LightPath manufactures a family of high-performance fiber-optic collimator products utilizing its proprietary technologies, including laser-fusion, laser-polishing and GRADIUM axial gradient-index glass. Garry Goodman, Director, Sales Western Region comments, "We worked closely with Avanex personnel to provide an optical system that would fit into their existing equipment yet improve overall system performance. Our engineering staff was able to leverage the unique properties of our GRADIUM(R) glass to provide a superior solution without increasing complexity or cost." Avanex Corporation develops, manufactures and delivers photonic processors for the communications industry, applying a unique mix of optical technology, micro-optic packaging expertise and network architecture knowledge. Avanex stock trades on the Nasdaq National Market under the stock symbol AVNX. They are headquartered in Fremont, CA. LightPath manufactures its proprietary collimator assemblies and GRADIUM(R) glass products at its headquarters in Albuquerque. The Company has recently announced the opening of a second office in Warren, NJ for the purpose of development of various optical switch products. The Company has 20 U.S. patents, plus 6 more pending, associated with its optical technologies. In addition, various foreign countries had issued a total of 7 patents with 10 patents pending. LightPath common stock trades on the Nasdaq SmallCap Market under the stock symbol LPTHA. This news release includes statements that may constitute forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. This information may involve risks and uncertainties that could cause actual results to differ materially from such forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, factors detailed by LightPath Technologies, Inc. in its public filings with the Securities and Exchange Commission. SOURCE LightPath Technologies, Inc.

To: Voltaire who wrote (6233)	3/6/2000 3:47:00 PM
From: Clappy	Read Replies (1) \| Respond to of 35685

Volts, Get up on the soap box if you would. Tell us more about LPTHA. I see they hold some patents for fiber optic lasers. Got any more dirt on them? -Clap

To: Voltaire who wrote (6233)	3/6/2000 4:33:00 PM
From: stockman_scott	Respond to of 35685

An Update on the Market...FYI... biz.yahoo.com Regards, Scott

To: Voltaire who wrote (6233)	3/6/2000 11:46:00 PM
From: jkc	Respond to of 35685

Voltaire, Lightpath is my favorite stock. Bought it in Dec of 97 when I hunted for a photonics company. Glad you like it since I always make a point of noticing what you are into.

To: Voltaire who wrote (6233)	3/7/2000 12:11:00 AM
From: jkc	Respond to of 35685

V, I should also mention that Lightpath's float will be larger due to warrant calling. I consider that good though as there will be more shares for funds to buy. They had a complicated capital structure which is almost all cleaned up. In the days when they went public, they were unique in that they had to become profitable after going public, not before. (the idea was that they were really more like a biotech at that time than anything.) That scenario may be common today but it wasn't back then. Someone reliable said that Goldman Sachs was buying today although I can't confirm it.